Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPRA | P18433 | 1/20 | 0.31 |
| ▸ | PTPRB | P23467 | 1/20 | 0.31 |
| ▸ | PTPRE | P23469 | 1/20 | 0.31 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25527397 | 0.90 | MAOB (0.35) | MAOBPOLBNLRP3 | |
| SCHEMBL25527337 | 0.88 | MAOB (0.37) | MAOBPOLBNLRP3TPMT | |
| SCHEMBL19678546 | 0.85 | MAOB (0.40) | MAOBPOLBNLRP3TPMTPTPRC | |
| SCHEMBL25529015 | 0.84 | — | — | |
| SCHEMBL19678534 | 0.84 | POLB (0.40) | MAOBPOLBNLRP3TPMTPTPRC | |
| SCHEMBL19678548 | 0.83 | MAOB (0.38) | MAOBPOLBNLRP3TPMTPTPRC | |
| SCHEMBL25527345 | 0.81 | MAOB (0.35) | MAOB | |
| SCHEMBL19683952 | 0.80 | MAOB (0.36) | MAOBPOLBNLRP3 | |
| SCHEMBL19678550 | 0.80 | MAOB (0.36) | MAOBPOLBNLRP3 | |
| SCHEMBL25527372 | 0.78 | TPMT (0.49) | POLBTPMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230152696-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |